APP13007 (Clobetasol Propionate Ophthalmic Nanosuspension) for the Treatment of Inflammation and Pain after Cataract Surgery

被引:0
|
作者
Levenson, Jeffrey [1 ]
Walters, Thomas R. [2 ]
Martel, Joseph [3 ]
Wang, Laurene [4 ]
Nunez, Derek [4 ]
机构
[1] Levenson Eye Associates, Jacksonville, FL USA
[2] Keystone Res, Austin, TX USA
[3] Martel Eye Med Grp, Rancho Cordova, CA USA
[4] AimMax Therapeut Inc, Durham, NC USA
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
F0131
引用
收藏
页数:3
相关论文
共 50 条
  • [22] Effect of pre-operative corticosteroid treatment on the inflammation after cataract surgery.
    Helintö, M
    Kirveskari, J
    Vesaluoma, MH
    Moilanen, JA
    Paavonen, T
    Renkonen, R
    Tervo, TM
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S572 - S572
  • [23] Difluprednate ophthalmic emulsion 0.05% (Durezol (R)) administered two times daily for managing ocular inflammation and pain following cataract surgery
    Smith, Stephen
    Lorenz, Douglas
    Peace, James
    McLeod, Kimberly
    Crockett, R. S.
    Vogel, Roger
    CLINICAL OPHTHALMOLOGY, 2010, 4 : 983 - 991
  • [24] Loteprednol etabonate gel 0.5% for postoperative pain and inflammation after cataract surgery: results of a multicenter trial
    Fong, Raymond
    Leitritz, Martin
    Siou-Mermet, Raphaele
    Erb, Tara
    CLINICAL OPHTHALMOLOGY, 2012, 6 : 1113 - 1124
  • [25] Reduced Posology of an Ophthalmic Hydrogel Containing Dexamethasone/Netilmicin to Prevent and Treat Ocular Inflammation After Cataract Surgery: Efficacy and Tolerability
    Rita Mencucci
    Thomas Ach
    Anja Liekfeld
    Antonio Scialdone
    Claudine Civiale
    Maria Grazia Mazzone
    Aldo Caporossi
    Advances in Therapy, 2022, 39 : 5474 - 5486
  • [26] Reduced Posology of an Ophthalmic Hydrogel Containing Dexamethasone/Netilmicin to Prevent and Treat Ocular Inflammation After Cataract Surgery: Efficacy and Tolerability
    Mencucci, Rita
    Ach, Thomas
    Liekfeld, Anja
    Scialdone, Antonio
    Civiale, Claudine
    Mazzone, Maria Grazia
    Caporossi, Aldo
    ADVANCES IN THERAPY, 2022, 39 (12) : 5474 - 5486
  • [27] Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery (vol 33, pg 53, 2007)
    Lane, S. S.
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2007, 33 (04): : 564 - 564
  • [28] Nonclinical Development of ENV905 (Difluprednate) Ophthalmic Implant for the Treatment of Inflammation and Pain Associated with Ocular Surgery
    Verhoeven, Rozemarijn S.
    Garcia, Andres
    Robeson, RiLee
    Gilger, Brian C.
    Culp, David
    Struble, Craig
    Hamm, Lee
    Navratil, Tomas
    Yerxa, Benjamin
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2018, 34 (1-2) : 161 - 169
  • [29] Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery
    Lane, Stephen S.
    Holland, Edward J.
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2013, 39 (02): : 168 - 173
  • [30] Multicenter randomized phase 3 study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation and pain after cataract surgery
    Tyson, Syd L.
    Bafna, Shamik
    Gira, Joseph P.
    Goldberg, Damien F.
    Jones, Jason J.
    Jones, Michael P.
    Kim, Janet K.
    Martel, Joseph M.
    Nordlund, Michael L.
    Piovanetti-Perez, Ian K.
    Singh, Inder Paul
    Metzinger, Jamie Lynne
    Mulani, Deepa
    Sane, Swati
    Talamo, Jonathan H.
    Goldstein, Michael H.
    Alpem, Louis
    Chu, Y. Ralph
    Desai, Neel
    Epitropoulos, Alice
    Kozlovsky, John F.
    Lesher, Mark
    Malhotra, Ranjan P.
    Peters, Newton T.
    Price, Francis W., Jr.
    Qamar, Tariq
    Silverstein, Steven M.
    Tekwani, Navin H.
    Vroman, David T.
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2019, 45 (02): : 204 - 212